Blog

Google has a ‘moonshot’ plan for AI data centers in space

Google has dreamed up a potential new way to get around resource constraints for energy-hungry AI data centers on Earth — launching its AI chips into space on solar-powered satellites. It’s a ‘moonshot’ research project Google announced today called Project Suncatcher. If it can ever get off the ground, the project would essentially create space-based […]

Google has a ‘moonshot’ plan for AI data centers in space Read More »

Can AI Really Think? Understanding the Limitations of Reactive Intelligence

The question of whether Artificial Intelligence (AI) can truly “think” is one that has captivated and divided researchers, philosophers, and the public alike. While AI has made incredible strides in recent years, from beating grandmasters at complex games to generating realistic images and text, it’s crucial to understand the nuances of what’s actually happening under

Can AI Really Think? Understanding the Limitations of Reactive Intelligence Read More »

The Power of ‘If-Then’: Exploring Reactive Machines and Their Applications

At the heart of countless automated systems lies a simple yet powerful concept: the ‘if-then’ statement. This fundamental logical construct forms the basis of reactive machines, which are systems designed to respond dynamically to changes in their environment. From everyday appliances to complex industrial robots, reactive machines are ubiquitous in the modern world. This article

The Power of ‘If-Then’: Exploring Reactive Machines and Their Applications Read More »

FDA described as a “clown show” amid latest scandal; top drug regulator is out

In September, Tidmarsh went after Tang’s Aurinia and its drug voclosporin that treats lupus nephritis, a disease in which the immune system attacks the kidneys. In a startling post on his LinkedIn account, Tidmarsh claimed that the FDA-approved drug had not been shown to provide “hard” clinical benefit and that the drugmaker had not performed

FDA described as a “clown show” amid latest scandal; top drug regulator is out Read More »